Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Virios Therapeutics (VIRI US)
Watchlist
1
Analysis
Health Care
•
United States
Virios Therapeutics, Inc. operates as a biotechnology company. The Company develops novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Virios Therapeutics serves patients in the United States.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Virios Therapeutics
•
14 May 2024 00:00
•
Issuer-paid
VIRI: Results for Phase 2 Long COVID Trial Expected in 2H24
On May 10, 2024, Virios Therapeutics, Inc. (VIRI) announced financial results for the first quarter of 2024 and provided a business update. The...
Zacks Small Cap Research
Follow
194 Views
Share
No more insights
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x